Makson Formulations Pvt Ltd

Makson Formulations Pvt Ltd

Produces and sells amylmetacresol since 1999 in Surendranagar, Gujarat.
1999 | Surendra Nagar, Gujarat (India) | Active

Last Updated:

November 16, 2024
HomeCompanyMakson Formulations Pvt Ltd

Who are the key members and board of directors at Makson Formulations?

Board Members(3)

NameDesignationAppointment DateStatus
Mahendrabhai Patel In Director 16-Sep-1999Current
Rajubhai Patel In Director 16-Sep-1999Current
Tusharbhai Patel In Director 16-Sep-1999Current

Financial Performance and Corporate Structure Insights of Makson Formulations.

Makson Formulations Pvt Ltd, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.56% decrease. The company also saw a substantial fall in profitability, with a 27.46% decrease in profit. The company's net worth moved up by a moderate rise of 0.5%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-0.56%
Revenue from Operations
Total Assets
0.66%
Profit or Loss
-27.46%
Net Worth
0.50%
EBITDA
-6.85%

Related Corporates (Common Directorship)

Charges (Loans)

Open Charges Satisfied Charges

₹291.80 M

₹215.00 M

LenderAmountStatus

Others

Creation Date: 11 Mar 2016
₹29.18 CrOpen

Rajkot Nagarik Sahakari Bank Ltd.

Creation Date: 07 Feb 2011
₹21.50 CrSatisfied

How Many Employees Work at Makson Formulations?

Unlock and access historical data on people associated with Makson Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Makson Formulations

Recent activity within the organization

  • Annual General Meeting

    Makson Formulations Pvt Ltd last Annual general meeting of members was held on 15 Sep 2024 as per latest MCA records.

    15 Sep 2024

  • Balance Sheet

    Makson Formulations Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.

    31 Mar 2024

  • Charges

    A charge with Others of Rs. 291.80 M registered on 11 Mar 2016 with Charge ID 100021538 was modified on 08 Dec 2022.

    08 Dec 2022

  • Charges

    A charge with Others amounted to Rs. 291.80 M with Charge ID 100021538 was registered on 11 Mar 2016.

    11 Mar 2016

  • Charges

    A charge registered on 07 Feb 2011 via Charge ID 10270637 with Rajkot Nagarik Sahakari Bank Ltd. was fully satisfied on 04 Feb 2016.

    04 Feb 2016

  • Charges

    A charge with Rajkot Nagarik Sahakari Bank Ltd. amounted to Rs. 215.00 M with Charge ID 10270637 was registered on 07 Feb 2011.

    07 Feb 2011

Frequently asked questions

  • Makson Formulations Pvt Ltd was incorporated on 16 Sep 1999.

  • The authorized share capital of Makson Formulations Pvt Ltd is ₹ 3.00 M and paid-up capital is ₹ 2.65 M.

  • Currently 3 directors are associated with Makson Formulations Pvt Ltd.

    • Mahendrabhai Chaturbhai Patel
    • Rajubhai Chaturbhai Patel
    • Tusharbhai Chaturbhai Patel
  • As per Ministry of Corporate Affairs (Mca), the registered address of Makson Formulations Pvt Ltd is 3 Kumbharpara P O No 18 Dist India, Surendranagar, Gujarat, 363002.

  • The corporate identification number (CIN) of Makson Formulations Pvt Ltd is U24110GJ1999PTC036580 and the company number is 036580 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2023, the revenue trend for Makson Formulations Pvt Ltd has fallen by -0.56%.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Makson Formulations Pvt Ltd has experienced an upsurge of 0.50%.

  • As per the financial statements for fiscal Year 2023, The total open charges for Makson Formulations Pvt Ltd amount to ₹ 29.18 Cr.

  • The most recent Balance Sheet for Makson Formulations Pvt Ltd was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development